Therapeutic Asset Ratings
91,564
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Dexasone
Acute Undifferentiated Leukemia
Therapeutic Advances in Childhood Leukemia Consortium
P3
BB
(70)
Dexasone
Amyloidosis
Ascentage Pharma Group Inc.
P3
BB
(70)
Dexasone
Metastasis From Malignant Tumor Of Colon
Fudan University
P3
BB
(70)
Dexasone
Hematopoietic And Lymphoid System Neoplasm
City of Hope Medical Center
P3
BB
(70)
Dexasone
Kidney Failure
Augusta University
P3
BB
(70)
Dlbs3233
Polycystic Ovary Syndrome
Inlacinpenelitian
P3
BB
(70)
Docetaxel
Prostate Carcinoma
Alliance for Clinical Trials in Oncology
P3
BB
(70)
Docetaxel
Primary Peritoneal Carcinoma
Genelux Corporation
P3
BB
(70)
Durvalumab
Urothelial Carcinoma
Alliance for Clinical Trials in Oncology
P3
BB
(70)
Elacestrant
Hormone Receptor-Positive Breast Cancer
West German Study Group
P3
BB
(70)
Epirubicin
Inflammatory Breast Carcinoma
Northwestern University
P3
BB
(70)
Etoposide
Lung Adenocarcinoma
Guangdong Association of Clinical Trials
P3
BB
(70)
Etoposide
Myelodysplastic Syndrome With Excess Blasts
M.D. Anderson Cancer Center
P3
BB
(70)
Etoposide
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
M.D. Anderson Cancer Center
P3
BB
(70)
Etoposide
T-Cell Childhood Acute Lymphocytic Leukemia
National Cancer Institute (NCI)
P3
BB
(70)
Fludarabine
Acute Megakaryoblastic Leukemia
Fred Hutchinson Cancer Center
P3
BB
(70)
Fludarabine
Acute Erythroid Leukemia
Fred Hutchinson Cancer Center
P3
BB
(70)
Fludarabine
Chronic Myeloid Leukemia
Ohio State University Comprehensive Cancer Center
P3
BB
(70)
Fluorouracilum
Anal Carcinoma
Federation Francophone de Cancerologie Digestive
P3
BB
(70)
Fluorouracilum
Gastroesophageal Junction Adenocarcinoma
Alliance for Clinical Trials in Oncology
P3
BB
(70)
Fluorouracilum
Metastatic Malignant Neoplasm
I-Mab Biopharma US Limited
P3
BB
(70)
Fulzerasib
Non-Small Cell Lung Carcinoma
Shandong Suncadia Medicine Co., Ltd.
P3
BB
(70)
Giredestrant
Estrogen-Receptor Positive Breast Cancer
Hoffmann-La Roche
P3
BB
(70)
Girentuximab
Kidney Cancer
Memorial Sloan Kettering Cancer Center
P3
BB
(70)
Glecirasib
Non-Small Cell Lung Carcinoma
Shandong Suncadia Medicine Co., Ltd.
P3
BB
(70)
Showing 1476 to 1500 of 42,327 assets
Previous
Page 60 of 1694
Next